Mon, Dec 5, 10:10 AM, Zacks
Increased Earnings Estimates Seen for VIVUS (VVUS): Can It Move Higher?
VIVUS (VVUS) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.
Thu, Dec 1, 3:20 PM, Zacks
5 Top Performing Biotechnology Stocks of November
November was a great month for pharma/biotech stocks after a rather difficult year when the industry struggled with media and political focus on high drug prices.